Merck & Co. Statistics
Total Valuation
Merck & Co. has a market cap or net worth of $292.01 billion. The enterprise value is $315.17 billion.
Important Dates
The last earnings date was Tuesday, February 3, 2026, before market open.
| Earnings Date | Feb 3, 2026 |
| Ex-Dividend Date | Mar 16, 2026 |
Share Statistics
Merck & Co. has 2.48 billion shares outstanding. The number of shares has decreased by -1.34% in one year.
| Current Share Class | 2.48B |
| Shares Outstanding | 2.48B |
| Shares Change (YoY) | -1.34% |
| Shares Change (QoQ) | -0.40% |
| Owned by Insiders (%) | 0.05% |
| Owned by Institutions (%) | 78.89% |
| Float | 2.48B |
Valuation Ratios
The trailing PE ratio is 16.16 and the forward PE ratio is 22.87. Merck & Co.'s PEG ratio is 2.46.
| PE Ratio | 16.16 |
| Forward PE | 22.87 |
| PS Ratio | 4.54 |
| Forward PS | 4.27 |
| PB Ratio | 5.64 |
| P/TBV Ratio | 19.53 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | 2.46 |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | 17.27 |
| EV / Sales | 4.85 |
| EV / EBITDA | 10.94 |
| EV / EBIT | 12.86 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.80 |
| Debt / EBITDA | 1.44 |
| Debt / FCF | n/a |
| Interest Coverage | 18.06 |
Financial Efficiency
Return on equity (ROE) is 37.17% and return on invested capital (ROIC) is 28.30%.
| Return on Equity (ROE) | 37.17% |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 28.30% |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | 5.51% |
| Revenue Per Employee | $866,813 |
| Profits Per Employee | $243,387 |
| Employee Count | 75,000 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Merck & Co. has paid $2.80 billion in taxes.
| Income Tax | 2.80B |
| Effective Tax Rate | 13.31% |
Stock Price Statistics
The stock price has increased by +34.80% in the last 52 weeks. The beta is 0.30, so Merck & Co.'s price volatility has been lower than the market average.
| Beta (5Y) | 0.30 |
| 52-Week Price Change | +34.80% |
| 50-Day Moving Average | 106.70 |
| 200-Day Moving Average | 89.03 |
| Relative Strength Index (RSI) | 64.46 |
| Average Volume (20 Days) | 14,023,816 |
Short Selling Information
The latest short interest is 33.65 million, so 1.36% of the outstanding shares have been sold short.
| Short Interest | 33.65M |
| Short Previous Month | 37.16M |
| Short % of Shares Out | 1.36% |
| Short % of Float | 1.36% |
| Short Ratio (days to cover) | 2.45 |
Income Statement
In the last 12 months, Merck & Co. had revenue of $65.01 billion and earned $18.25 billion in profits. Earnings per share was $7.28.
| Revenue | 65.01B |
| Gross Profit | 50.11B |
| Operating Income | 24.50B |
| Pretax Income | 21.07B |
| Net Income | 18.25B |
| EBITDA | 28.80B |
| EBIT | 24.50B |
| Earnings Per Share (EPS) | $7.28 |
Full Income StatementBalance Sheet
The company has $18.21 billion in cash and $41.37 billion in debt, with a net cash position of -$23.16 billion or -$9.33 per share.
| Cash & Cash Equivalents | 18.21B |
| Total Debt | 41.37B |
| Net Cash | -23.16B |
| Net Cash Per Share | -$9.33 |
| Equity (Book Value) | 51.91B |
| Book Value Per Share | 20.85 |
| Working Capital | n/a |
Full Balance SheetMargins
Gross margin is 77.08%, with operating and profit margins of 37.69% and 28.08%.
| Gross Margin | 77.08% |
| Operating Margin | 37.69% |
| Pretax Margin | 32.41% |
| Profit Margin | 28.08% |
| EBITDA Margin | 44.30% |
| EBIT Margin | 37.69% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of $3.40, which amounts to a dividend yield of 2.89%.
| Dividend Per Share | $3.40 |
| Dividend Yield | 2.89% |
| Dividend Growth (YoY) | 5.06% |
| Years of Dividend Growth | 15 |
| Payout Ratio | 45.60% |
| Buyback Yield | 1.34% |
| Shareholder Yield | 4.23% |
| Earnings Yield | 6.25% |
| FCF Yield | n/a |
Dividend DetailsAnalyst Forecast
The average price target for Merck & Co. is $121.00, which is 2.85% higher than the current price. The consensus rating is "Buy".
| Price Target | $121.00 |
| Price Target Difference | 2.85% |
| Analyst Consensus | Buy |
| Analyst Count | 13 |
| Revenue Growth Forecast (5Y) | 1.86% |
| EPS Growth Forecast (5Y) | 6.23% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
Stock Splits
The last stock split was on February 17, 1999. It was a forward split with a ratio of 2:1.
| Last Split Date | Feb 17, 1999 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |
